TY - JOUR
T1 - Successful ventilator weaning by trastuzumab in a HER2-positive breast cancer patient with multiple lung metastases
AU - Matsuda, Takeru
AU - Fujita, Hirofumi
AU - Kunimoto, Yukihiro
AU - Hosono, Masayoshi
AU - Kimura, Taisei
AU - Hayashi, Tomomi
AU - Maeda, Toshiyuki
AU - Yamakawa, Junichi
AU - Maeda, Norikatsu
AU - Mizumoto, Takuya
AU - Maruyama, Shoko
AU - Uenaka, Yuko
AU - Ogino, Kazunori
PY - 2013/6
Y1 - 2013/6
N2 - We report a case of breast cancer with severe respiratory dysfunction due to multiple lung metastases, which was recovered by treatment with weekly trastuzumab administration. A 47-year-old woman with breast cancer had received a folk remedy from a general practitioner for 4 years. However, she was delivered to a hospital because of severe dyspnea, and intubation was found to be needed and performed. She was diagnosed with left breast cancer with skin and pleural wall invasion, and multiple lung metastases. Pathological examination showed invasive ductal carcinoma which was ER-postive, PgR-negative, and HER2-postive. After transfer to our hospital, treatment with trastuzumab (4 mg/kg/weekly for the first course, and 2 mg/kg/weekly thereafter) was administered. Respiratory function improved gradually, and ventilator weaning was successful at 53 days after trastuzumab administration. CT examination also showed a remarkable reduction of lung and lymph node metastases and pleural effusion. She was discharged from our hospital 80 days after treatment, and her treatment with trastuzumab and capecitabine has been ongoing at an outpatient clinic.
AB - We report a case of breast cancer with severe respiratory dysfunction due to multiple lung metastases, which was recovered by treatment with weekly trastuzumab administration. A 47-year-old woman with breast cancer had received a folk remedy from a general practitioner for 4 years. However, she was delivered to a hospital because of severe dyspnea, and intubation was found to be needed and performed. She was diagnosed with left breast cancer with skin and pleural wall invasion, and multiple lung metastases. Pathological examination showed invasive ductal carcinoma which was ER-postive, PgR-negative, and HER2-postive. After transfer to our hospital, treatment with trastuzumab (4 mg/kg/weekly for the first course, and 2 mg/kg/weekly thereafter) was administered. Respiratory function improved gradually, and ventilator weaning was successful at 53 days after trastuzumab administration. CT examination also showed a remarkable reduction of lung and lymph node metastases and pleural effusion. She was discharged from our hospital 80 days after treatment, and her treatment with trastuzumab and capecitabine has been ongoing at an outpatient clinic.
UR - http://www.scopus.com/inward/record.url?scp=84882753552&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84882753552&partnerID=8YFLogxK
M3 - Article
C2 - 23863656
AN - SCOPUS:84882753552
SN - 0385-0684
VL - 40
SP - 773
EP - 776
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
IS - 6
ER -